跳至主要内容
临床试验/CTRI/2024/02/062688
CTRI/2024/02/062688招募中4 期

Prospective, single arm, post-marketing clinical study of EYECRYLâ„¢ PLUS (600) intraocular lens to assess performance and safety in patients undergoing cataract surgery.

Biotech vision care pvt ltd1 个研究点 分布在 1 个国家目标入组 850 人开始时间: 2024年3月15日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
850
试验地点
1
主要终点
Percentage of eyes that will achieve distance

研究概览

简要总结

The objectives of this study are to evaluate safety and performance of EYECRYLâ„¢ PLUS (600), a Monofocal Hydrophillic clear Acrylic Foldable Intraocular Lens in patients undergoing cataract surgery, to evaluate monocular uncorrected distance visual acuity (UCVA) and distance corrected visual acuity (BCVA) under photophic conditions and to measure the Contrast Sensitivity

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Age 18 year or greater
  • Calculated IOL power is within the range of the investigational IOL.
  • Clear intraocular media other than cataract
  • Patient willing to participate and sign informed consent to participate in study and to use device related data for scientific purpose
  • Patient willing to come for all post-operative follow-up
  • Female participants of child bearing potential and male participants whose partner is of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study.

排除标准

  • Previous intraocular or corneal surgery
  • Traumatic cataract
  • Pregnancy
  • Vulnerable subject.
  • Patients receiving chloroquine treatment.
  • Patient having Microphthalmia.
  • Patient having Chronic Uveitis.
  • Patient suffering from corneal dystrophy or endothelial insufficiency.
  • Patient having active ocular diseases (active diabetic retinopathy, uncontrolled glaucoma.

结局指标

主要结局

Percentage of eyes that will achieve distance

时间窗: Percentage of eyes that will achieve distance | uncorrected visual acuity within (0.3 logMAR or | better) at 180 days post operatively.

uncorrected visual acuity within (0.3 logMAR or

时间窗: Percentage of eyes that will achieve distance | uncorrected visual acuity within (0.3 logMAR or | better) at 180 days post operatively.

better) at 180 days post operatively.

时间窗: Percentage of eyes that will achieve distance | uncorrected visual acuity within (0.3 logMAR or | better) at 180 days post operatively.

次要结局

  • To assess safety of EYECRYLâ„¢ PLUS 600(intraocular lens in patients undergoing cataract)

研究者

发起方
Biotech vision care pvt ltd
申办方类型
Other [Medical device industry]
责任方
Principal Investigator
主要研究者

DR UDAY GAJIWALA

Tejas eye hospital

研究点 (1)

Loading locations...

相似试验